364 an human 7TM 366 aa rat (IJZSOZS) 7TM
(8.5-9.6)
ligands: bradykinin
(BK), BK,_,, kallidin (Lys-BK), T-kinin (Ile-Ser-BK), [Hyp”]bradykinin,
‘ides-Arg]BK; the presence of 8, receptors is most easity indicated by the activity of BK,,
Endogenous
are antagonists
[Hyp4]kallidin
Other receptors~inding sites: The existence of B, receptors in guinea-pig airways has been proposed. Certain [DPhe7J-subst~tuted analugues of bradykinin at B, receptors but are claimed to be inactive at B, receptors. The variation in pA, values of antagonists at 8, receptors may reflect the existence of receptor subtypes or species homologues.
-
Structural information
IPJ DG b2
-
Predominant effecters
[“H]DArg[Proz,HypJ,Thii,DTic’,Ticfi]BK [1251]-fTyr#]BK [W]BK
Gene
PHlBKj-s
Radioligands
~Hyp~,Tyr(M~)~]BK
Sarjt~PheRJBK,, HOE140 (7.5-10.5) uArg[Hyp”,ThiSs4uPhe7JBK (6.0-7.5) oArg[Hyp”,This,HypE(Ir9rrs-propyl)70icH]BK DAr~[~yp~,DPhe’,Leu~]BK (6.8-7.9)
~Phe”,~(~H~-NH)Ar~~]BK
B&.8*
Selective agonists
[LeuH]BKI_8(6.7-7.3) [des-Arg’“]HOEl40
knllidin 2 BK 2:’ BK,..,
BK,_, = kallidin > BK
l?otency order
Selective antagonists
EK2
F2
SKI
Bl
Previous names
Nomenclature